Kinome reprogramming in neuroblastoma manuscript published!

From Dr. Yael Mosse’s laboratory, we are happy to see the work of Dr. Smita Matkar, “Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastoma”, published today. We were happy to have played a small role in this work! Read more about it here.